Category: Tobacco

Articles on harmful effects and impact of Tobacco in our lifestyle. Remedies to Quit Tobacco easily and much more. Keep Reading.

PRISm – A COPD Risk factor and Smoking Cessation advocated by ICanCaRe

Introduction:

Preserved Ratio Impaired Spirometry (PRISm) is a critical indicator characterized by an FEV1 of <80% predicted and a FEV1/FVC ratio of >0.70. Identified as a precursor to Chronic Obstructive Pulmonary Disease (COPD), PRISm demands careful monitoring, particularly in individuals with respiratory symptoms. The studies by Mariko Kogo et al. and Daniel H Higbee et al. shed light on the significant correlation between PRISm, respiratory symptoms, and the heightened risk of developing COPD, emphasizing the urgency for effective tobacco cessation interventions. In this context, the ICanCaRe tobacco cessation intervention program emerges as a beacon of hope, advocating for smoking cessation on an individual basis. (www.icancare.in). This blog is in series with the previous blog on Increased risk of Asthma in Children exposed to secondhand smoke.( ICanCaRe Blog) (ICanCaRe LinkedIn)

Understanding the PRISm Challenge:

PRISm, when associated with respiratory symptoms such as cough, sputum, and dyspnea, poses an independent risk factor for COPD development, especially in individuals with a history of smoking. Even without symptoms at baseline, PRISm can progress within five years, leading to airflow limitations. In addition, individuals with PRISm could exhibit increased respiratory symptoms, poor health-related quality of life, multiple comorbidities, and increased mortality compared with those with normal spirometry. The quantitative assessment capability of PRISm becomes a crucial tool for identifying and addressing the risks faced by smokers, reinforcing the need for smoking cessation.

The ICanCaRe Tobacco Cessation Intervention program quantifies the need for individuals and the digital protocol puts the urgency for smoking cessation on an individual basis.

ICanCaRe: A Holistic Approach to Tobacco Cessation:

ICanCaRe tobacco cessation wellness program stands out as a comprehensive, evidence-based tobacco cessation program aligned with the latest research findings. Grounded in the insights from studies by Kogo et al. and Higbee et al., ICanCaRe adopts a holistic approach to empower individuals to overcome addiction, ensuring long-term abstinence, and reducing the risk of respiratory complications.

Key Components of ICanCaRe – ABCD of Tobacco Cessation:

1. ACTIVE MOTIVATION: ICanCaRe actively motivates tobacco users through quantitative and qualitative assessments, estimating the progressive risk associated with continued smoking.

2. BEHAVIOR INTERVENTION: Tailored behavioral counseling strategies address unique triggers contributing to tobacco addiction, crucial for addressing psychological aspects and enhancing successful cessation.

3. COMORBIDITY MANAGEMENT: Clinical assessments for associated morbidities are conducted, with specialists providing personalized care.

4. DRUGS and MEDICATIONS – Pharmacotherapy: The program integrates evidence-based pharmacotherapies to manage withdrawal symptoms and cravings, enhancing the effectiveness of the intervention and ensuring complete cessation.

Call 011-43077695 or write to info@icancare.in and download the ICanCaRe tobacco Wellness APP (http://app.icancare.in)

Conclusion – Empowering Individuals for a Tobacco-Free Future:

As we confront the challenges posed by PRISm and its link to respiratory symptoms, the ICanCaRe Tobacco Cessation Intervention program stands as a beacon of hope. By integrating the latest research findings into its framework, ICanCaRe not only recognizes the severity of the issue but actively addresses it through a personalized and holistic approach. It serves as a call to action for individuals to take charge of their respiratory health, break free from tobacco addiction, and embrace a future free from the shackles of compromised lung function.

ICanCaRe stands at the forefront of the battle against tobacco addiction, offering a lifeline to those grappling with the consequences of PRISm. Through its holistic approach, the program not only supports individuals in their journey to quit smoking but also contributes to a healthier, tobacco-free future for communities worldwide.

It is time we #savetheyouth. SAVE our next generation!! #knowtobacco to #notobacco

Reference:

1. Mariko Kogo et al. Longitudinal changes and association of respiratory symptoms with preserved ratio impaired spirometry (PRISm): The Nagahama Study. Ann Am Thorac Soc. 2023 Nov;20(11):1578-1586. doi: 10.1513/AnnalsATS.202301-050OC.

2. Daniel H Higbee et al. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis. Lancet Respir Med. 2022 Feb;10(2):149-157. doi: 10.1016/S2213-2600(21)00369-6.

Author –

1. Dr Shikha Jindal Consultant Pulmonologist Dr Shikha Jindal Gupta MD, CTCS(GU)

– Sr Consultant Pulmonologist,

– Certified Tobacco Cessation Specialist (Gujarat University by ICanCaRe)

Neo Super-Speciality Hospital, Noida

2. Dr Pawan Gupta M.Ch. Cancer Surgeon

 –  Sr. Director, Surgical Oncology

MAX Institute of Cancer Care, Vaishali, Patparganj and Noida

–          Founder Director – ICanCaRe – Innovative Cancer Care and Rehabilitation ICanCaRe, ICanCaRe Academy

–          Master Trainer – Tobacco Cessation Courses, Oral Cancers

#icancare #asthmaawareness #secondhandsmoke #icancareapp #pawangupta #icancareacademy #knowtobacco #Prism #COPD #smoking #quitsmoking

Suneela Garg Dr. Paramita Sengupta Rakesh Gupta Dr Pawan Gupta Dr REENA R KUMAR Shruti Agrawal Rishabh Agrawal Dr. Siddhi Hathiwala Dr Neha Agrawal ICanCaRe – Innovative Cancer Care and Rehabilitation Dr Shikha Jindal Consultant Pulmonologist

“ICanCaRe: A Critical Response to the Increased Risk of Asthma Hospitalization in Children Exposed to Second-hand Smoke”

“ICanCaRe: A Critical Response to the Increased Risk of Asthma Hospitalization in Children Exposed to Second-hand Smoke”

A pivotal study published in the Annals of Allergy, Asthma & Immunology reveals a concerning correlation between second-hand smoke exposure and increased hospitalization risks in children with bronchial asthma, particularly following infections like respiratory syncytial virus (RSV).[1,2] This underscores the urgency of interventions like the ICanCaRe tobacco cessation program. (www.icancare.in)

Conducted by researchers from Kyushu University, Fukuoka, Japan, the study examined the impact of second-hand smoke on 2248 children who had a history of RSV infection and 444 children with a history of human metapneumovirus (hMPV) infection. Among these, 56 children had experienced both infections. The study, which sourced data from the Japan Health Insurance Association database (April 2004 to March 2017), reported that 38% of children with RSV infection, 40% with hMPV infection, and 39% with both infections were exposed to second-hand smoke.

The findings were alarming: hospitalization rates for asthma control were significantly higher in children exposed to second-hand smoke (4.5%) compared to their non-exposed counterparts (2.7%). Furthermore, the diagnosis of bronchial asthma occurred earlier in the exposed group, with a median age of 22 months, as opposed to 25 months in the unexposed group.

For children who developed hMPV infection at 12 months or older, those exposed to second-hand smoke were diagnosed with bronchial asthma at an average age of 33 months, compared to 47 months in non-exposed children. Notably, in children who had hMPV infection before 12 months, there were no hospitalizations in the second-hand smoke group.[2]

The study also highlighted those children with pre-existing bronchial asthma and RSV infection faced a greater risk of hospitalization if exposed to second-hand smoke. The odds ratio (OR) for hospital admission due to asthma exacerbation in these children was 1.69. [2]

The synergy between viral infections like RSV, hMPV, and second-hand smoke exposure in exacerbating bronchial asthma is a critical public health concern. This study not only points to the heightened risk of pediatric asthma but also to the urgent need for protective measures against second-hand smoke exposure.

The ICanCaRe digitalized tobacco cessation program (www.icancare.in) emerges as a beacon of hope in this scenario. By focusing on tobacco cessation and raising awareness about the dangers of second-hand smoke, ICanCaRe is positioned to play a pivotal role in mitigating the risk of pediatric asthma, especially in vulnerable children with a history of RSV or hMPV infections. With the #advicequittobacco campaign, we implore all doctors to ask and advice about tobacco use and quitting and refer them to the ICanCaRe centers for a 100% successful quit program. Call 011-43077695 or write to info@icancare.in and download the ICanCaRe tobacco Wellness APP (http://app.icancare.in)

Through programs like ICanCaRe, there is potential to reduce the onset and severity of pediatric asthma, providing a healthier future for our children as part of the prime campaign #SAVEtheYouth. The findings of this study serve as a powerful reminder of the critical importance of such interventions.

References:

1. Yoshizato R, et al. Secondhand smoking and pediatric asthma after respiratory syncytial virus or human metapneumovirus infection. Ann Allergy Asthma Immunol. 2023 Oct 18:S1081-1206(23)01342-X. doi: 10.1016/j.anai.2023.10.013.

2. Stong C. Available at: https://www.pulmonologyadvisor.com/home/topics/lung-infection/secondhand-smoke-rsv-and-pediatric-bronchial-asthma/. Dated Nov. 10, 2023. Accessed on Nov. 14, 2023.

#icancare #asthma #secondhandsmoking #icancareapp

#15th ICanCaRe Tutorial for Certified Tobacco Cessation Specialists

On November 20, 2023, the 15th tutorial for Certified Tobacco Cessation Specialists was held, marked by a productive collaboration between Dr. Mariya, Dr. Siddhi, Dr. Anshika, and the new addition to the coordinator team, Dr. Abhishek Bhadranna.

Agenda Highlights:

1. Case Discussion on PAAN Cessation: Dr. Anshika Pandey presented a compelling case of a paan (betel leaf) consumer and shared the successful guidance provided to help the individual quit this habit.

2. Integration of WHO Guidelines on Tobacco and Diabetes: Dr. Rakesh Gupta from SIPHER and Dr. Pawan Gupta led a discussion on the recent WHO guidelines concerning tobacco and its connection to diabetes. They highlighted how ICanCaRe has incorporated these guidelines into the ABCD model for comorbidity management.

3. Turning Tobacco Cessation into a Success Story: Participants engaged in a thoughtful dialogue on transforming tobacco cessation into a successful endeavor. The focus was on building confidence and establishing a strong identity in the field of tobacco cessation. Attendees were tasked with creating their professional identity, including designing visiting cards and flyers.

4. Special Pricing for Tobacco-Related Medications: Information regarding exclusive pricing for tobacco-related medications for CTCS in clinic settings was shared to facilitate more accessible treatment options.

5. Acknowledging ICanCaRe: Dr. Pawan Gupta emphasized the importance of CTCS acknowledging ICanCaRe in all their presentations, both online and offline, to strengthen the collective mission.

Members’ Feedback:

– Siddhi continued to express her appreciation for the ongoing opportunities for learning and professional growth.

– Abhishek expressed gratitude to all participants for their valuable contributions and highlighted the wealth of knowledge gained during the session.

– Rakesh commended the inclusion of comorbidity management into ICanCaRe cessation and emphasized the tutorial’s importance for anyone looking to excel in the field.

– Dr. Rajkumari underscored the tutorial’s role in enhancing learning and skill development.

– Kshipra expressed gratitude for the enriching learning experience.

ICanCaRe Academy Tutorial for Certified Tobacco Cessation Specialists (CTCS) is a monthly program held on the 15th of each month, from 9-10 PM. The program encourages CTCS to present complex cases on tobacco cessation for discussion and finding solutions to facilitate successful quitting. To submit cases or for further information, individuals can contact Dr. Mariya, Dr. Siddhi, Dr. Anshika, or Dr. Abhishek.

ICanCaRe Academy encourages active participation in these monthly sessions to gain profound insights into practical tobacco cessation through case discussions. Aspiring Certified Tobacco Cessation Specialists can explore the certification process at www.icancare.in/academy/ctcs

Stay connected with us on social media:

#icancareacademy #icancaretutorial #icancare #siddhi #pawangupta #CTCS #icancare #mariya #anshikapandey #abhishekbhadranna